Cargando…
Are Patients with HHV-8 Associated Castleman Disease Successfully Treated with Rituximab at Risk of Subsequently Developing HHV-8 Negative (Idiopathic) Castleman Disease?
INTRODUCTION: Multicentric Castleman disease (MCD) is a lymphoproliferative disorder characterized by lymph node histopathology and systemic symptoms. To our knowledge, there are no descriptions in the literature of long-term outcomes of human herpesvirus-8 (HHV-8)-associated MCD. CASE DESCRIPTION:...
Autores principales: | Ha, Gavin, Kwong, Kelsey, Tanaka, Bryce, Nishimura, Yoshito, Chong, Christina |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SMC Media Srl
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10348438/ https://www.ncbi.nlm.nih.gov/pubmed/37455698 http://dx.doi.org/10.12890/2023_003904 |
Ejemplares similares
-
Steroids/tacrolimus: HHV-8 related multicentric Castleman disease : case report
Publicado: (2021) -
Higher rate of progression in HIV(–) than in HIV(+) patients after rituximab for HHV8(+) multicentric Castleman disease
por: Rasmussen, Camille, et al.
Publicado: (2023) -
A case of Castleman disease with hemophagocytic syndrome derived from HHV8 infection
por: Cui, Xiao, et al.
Publicado: (2021) -
Three patients with both Hodgkin's lymphoma and Castleman's disease: Clinicopathologic correlations and lack of association with HHV-8
por: Haque, Saadiya, et al.
Publicado: (2009) -
HHV-8-negative multicentric Castleman disease presenting as a crescentic immune complexes membranoproliferative glomerulonephritis
por: Nunes, Maria Brito, et al.
Publicado: (2020)